Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Rehab Efficacy and MDD Prevention in Older Adults
NCT00183729Phase 4Completed
- Start
- Aug 2005
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of memantine in major depressive disorder (MDD). Primary endpoint: Depressive Symptoms at 12 weeks. Started Aug 2005; status: completed.
02
Drugs
memantine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00183729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183729.